发明名称 substituted 4-(carboxybenzylsulphinyl)-2-oxo-azetidine derivatives
摘要 The 2-oxo-azetidin-1-yl derivative has the formula I wherein: R1 is H or the corresponding pharmaceutically acceptable ester or pharmaceutically acceptable salt thereof; R2 and R3 are independently H or optionally substituted alkyl; X is X'-(CH2)m or an alkylene chain optionally interrupted by X'; X' is CO, CONR4, COO, CONR4CO, CONHCO or CH2O; R4 is H or alkyl; m is 0 to 12; Y is an optionally substituted aryl group. The 2-oxo-azetidin-1-yl has an absolute configuration (4R, SS). A pharmaceutical composition thereof is useful for treating atherosclerosis, diabetes, hypertension, angina pectoris, reperfusion stoke, sepsis, psoriasis or schizophrenia.
申请公布号 NZ332476(A) 申请公布日期 2000.06.23
申请号 NZ19970332476 申请日期 1997.04.15
申请人 SMITHKLINE BEECHAM PLC 发明人 LEACH, COLIN ANDREW;HICKEY, DEIRDRE MARY BERNADETTE;IFE, ROBERT JOHN;DHANAK, DASHYANT;THEOBALD, COLIN
分类号 A61K31/00;A61K31/395;A61K31/397;A61P3/00;A61P3/10;A61P9/00;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P25/04;A61P29/00;A61P39/00;A61P39/06;A61P43/00;C07D205/09;C07D405/12;(IPC1-7):C07D205/09 主分类号 A61K31/00
代理机构 代理人
主权项
地址